A Prospective Study of Hypofractionated Proton Beam Therapy for Patients With Hepatocellular Carcinoma

Hypofractionated proton beam therapy is safe and well-tolerated by patients with HCC located greater than 2 cm away from the porta hepatis or gastrointestinal tract and may be effective alternative to other modalities.